CIK 0001438533
- Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 262383102
- Phone
- +1 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $79,495,607
- in 10 filings, $79.5M under 10b5-1 plans
Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dube Eric M −$38.5M CHIEF EXECUTIVE OFFICER sold 60% of stake
- Heerma Peter −$17.9M EVP, CHIEF COMMERCIAL OFFICER sold 71% of stake
- ROTE WILLIAM E. −$13.1M Chief Research Officer sold 68% of stake
- Cline Christopher R. −$3.2M CHIEF FINANCIAL OFFICER sold 37% of stake
- Inrig Jula −$2.8M EVP, Head of R&D & CMO sold 31% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-12 | Clague Laura Chief Financial Officer | Sale | −1,250 | $17.16 | $21K | 20,000 |
| 2020-05-12 | Clague Laura Chief Financial Officer | Sale | −527 | $16.98 | $9K | 19,473 |
| 2020-05-12 | Rosenberg Noah L. Chief Medical Officer | Sale | −527 | $16.98 | $9K | 26,728 |
| 2020-05-11 | REED ELIZABETH E SVP, GC & Corporate Secretary | Sale | −525 | $14.95 | $8K | 26,483 |
| 2020-05-11 | ROTE WILLIAM E. Senior Vice President, R&D | Sale | −813 | $14.95 | $12K | 24,833 |
| 2020-05-11 | Clague Laura Chief Financial Officer | Sale | −1,250 | $14.95 | $19K | 21,250 |
| 2020-05-05 | ASELAGE STEVE Director | Sale | −2,500 | $15.88 | $40K | 253,857 |
| 2020-04-08 | Bruhn Suzanne Louise Director | Grant or award | +5,250 | 5,250 | ||
| 2020-04-08 | Bruhn Suzanne Louise Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2020-03-10 | ROTE WILLIAM E. Senior Vice President, R&D | Sale | −3,250 | $14.87 | $48K | 25,646 |
| 2020-03-10 | REED ELIZABETH E SVP, GC & Corporate Secretary | Sale | −3,500 | $15.02 | $53K | 27,008 |
| 2020-03-10 | Clague Laura Chief Financial Officer | Sale | −4,000 | $15.02 | $60K | 22,500 |
| 2020-03-05 | ROTE WILLIAM E. Senior Vice President, R&D | Grant or award | +3,250 | 28,896 | ||
| 2020-03-05 | REED ELIZABETH E SVP, GC & Corporate Secretary | Grant or award | +3,500 | 30,508 | ||
| 2020-03-05 | Clague Laura Chief Financial Officer | Grant or award | +4,000 | 26,500 | ||
| 2020-03-05 | Rosenberg Noah L. Chief Medical Officer | Grant or award | +5,000 | 29,045 | ||
| 2020-03-05 | Rosenberg Noah L. Chief Medical Officer | Sale | −1,790 | $15.36 | $27K | 27,255 |
| 2020-03-05 | ASELAGE STEVE Director | Grant or award | +12,250 | 260,716 | ||
| 2020-03-05 | ASELAGE STEVE Director | Sale | −4,359 | $15.36 | $67K | 256,357 |
| 2020-02-18 | ROTE WILLIAM E. Senior Vice President, R&D | Sale | −1,250 | $16.55 | $21K | 25,646 |
Page 43 of 51 · 1,020 trades